PULSE BIOSCIENCES INC
PLSENASDAQTrading Snapshot
- Day Range
- $54.59 – $56.28
- 52-Week Range
- $12.56 – $58.90
- Volume (shares)
- 19,300
- Avg Volume (shares)
- —
- Shares Outstanding
- 71.3M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $350,000
- Last Q Revenue
- $434,000
- P/E Ratio
- —
- P/S Ratio
- 3232.0x
- EPS (TTM)
- $-1.17
- Dividend Yield
- —
PULSE BIOSCIENCES INC
PLSEFinancial history unavailable.
StockOtter · stockotter.spaceAbout PULSE BIOSCIENCES INC
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
ⓘLatest News & Updates
News unavailable.